Dr. Russell Tonkovich’s practice focuses on patent litigation and monetization. He is the Co-Chair of the firm’s Pharmaceutical & Life Sciences Practice focused on representing generic pharmaceutical companies in Hatch Waxman litigation. Russell is a nationally recognized patent litigator who has won verdicts in some of the largest patent infringement cases in the country. In 2023, he was selected as among the top 50 best performing and most active patent litigation attorneys in the United States, according to Patexia’s 2023 Patent Litigation Intelligence Report, for his work during the period 2017 through 2022. Russell successfully leads patent litigation teams to success at trial in district courts and the PTAB, and has achieved significant settlements for his clients.
Russell has represented Fortune 500 companies as well as startup companies in patent litigation involving a wide variety of technologies relating to pharmaceuticals, biotechnology, DNA arrays and sequencing, semiconductors, LED technology, smartphones and tablets, consumer electronics, optical networking, internet technologies, computer software, and computer networking.
Russell has represented both plaintiffs and defendants in variety of venues throughout the country including in district courts, the Patent Trials and Appeals Board, and the International Trade Commission. Russell also has significant experience representing clients in the Federal Circuit regarding appeals and writs of mandamus.
Russell has over 19 years of experience in patent litigation. Prior to joining Kramer Alberti, Russell worked at Wilmer Hale and Kirkland & Ellis as a patent litigator.
Harvard Law School
Medical Doctor (M.D.)
University of Illinois
Bachelor of Science (with Honors), Biochemistry
University of Wisconsin-Madison
Registered to practice before the USPTO
International Trade Commission